Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-27

Clinical Trial Update: Efficacy of Trans-tympanic Injections of a Sodium Thiosulfate Gel to Prevent Cisplatin-induced Ototoxicity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium thiosulfate gel (Sodium thiosulfate gel)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: DDP, Head and Neck Cancer | Phase 2 | Status: TERMINATED